文献速递皮肤肿瘤

睾丸生殖细胞肿瘤幸存者的皮肤癌风险:系统综述与荟萃分析

Skin cancer risk among testicular germ-cell cancer survivors: a systematic review and meta-analysis.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2022-02-09

该系统综述与荟萃分析纳入19项研究、147 935例睾丸生殖细胞肿瘤(TGCT)幸存者,汇总标准化发病比(SIR)显示TGCT幸存者皮肤癌SIR为1.93(95%CI 1.62-2.29,P<0.0001),黑色素瘤SIR为1.81(95%CI 1.57-2.08,P<0.0001),均高于一般人群。作者结论认为TGCT幸存者皮肤癌和黑色素瘤风险增加,需进一步开展长期研究。

要点

  • TGCT幸存者皮肤癌汇总SIR为1.93(95%CI 1.62-2.29,P<0.0001)。
  • TGCT幸存者黑色素瘤汇总SIR为1.81(95%CI 1.57-2.08,P<0.0001)。
  • 作者认为需进一步开展纳入TGCT幸存者、其他危险因素及所有皮肤癌亚型的长期研究。

核心结论

  • 与一般人群相比,TGCT幸存者发生皮肤癌和黑色素瘤的风险增加。
  • 作者认为需要进一步开展纳入TGCT幸存者、其他危险因素及所有皮肤癌亚型的长期研究。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、EMBASE、Web of Science、Cochrane Databases及参考文献列表。
  • 纳入报告皮肤癌发病且TGCT幸存者超过10例的所有比较研究。
  • 采用随机效应模型合并研究特异的对数转换估计值计算标准化发病比(SIR)。
  • 采用纽卡斯尔-渥太华质量评估量表评估偏倚风险。
  • 共纳入19项研究,报告147 935例TGCT幸存者。

主要发现

  • TGCT幸存者皮肤癌汇总SIR为1.93(95%CI 1.62-2.29,P<0.0001)。
  • TGCT幸存者黑色素瘤汇总SIR为1.81(95%CI 1.57-2.08,P<0.0001)。

关键数值与推荐

  • TGCT幸存者皮肤癌SIR为1.93(95%CI 1.62-2.29,P<0.0001)。
  • TGCT幸存者黑色素瘤SIR为1.81(95%CI 1.57-2.08,P<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为需要进一步开展纳入TGCT幸存者、其他危险因素及所有皮肤癌亚型的长期研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Testicular germ-cell tumours (TGCT) are the most common cancer among young adult men. Previous studies suggested TGCT survivors have an increased risk for skin cancer. The goal of this study was to systematically review the literature and evidence regarding skin cancer risk among TGCT survivors compared with the general population. PubMed, EMBASE, Web of Science, Cochrane Databases and reference lists were included in the search. A systematic review of all comparative studies with more than 10 TGCT survivors reporting on skin cancer incidence was performed. A meta-analysis of the Standardized Incidence Rate (SIR) was calculated by pooling study-specific log-transformed estimates using the random-effects model. Risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale. Nineteen studies that reported on 147 935 TGCT survivors were included. Pooled SIR for skin cancer and for melanoma incidence among TGCT survivors were 1.93 (95% CI 1.62-2.29, P < 0.0001) and 1.81 (95% CI 1.57-2.08, P < 0.0001), respectively. In conclusion, compared to the general population, TGCT survivors have an increased risk for developing skin cancer and melanoma. Additional long-term studies that include TGCT survivors, additional risk factors and all subtypes of skin cancer are required.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Reiter O, Voss VB, Fluss R, et al. Skin cancer risk among testicular germ-cell cancer survivors: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2022. PMID: 35034398. doi:10.1111/jdv.17932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。